234080.KS
JW Lifescience Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 10,590.00
+0.76%Next report
Analyst consensus
- Next report date
- Nov 16, 2026
- EPS estimate
- —
- Revenue estimate
- KRW 66.7B
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- KRW 376
- EPS estimate
- —
- Revenue actual
- KRW 56.7B
- Revenue estimate
- KRW 66.7B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | — | KRW 376 | — | KRW 56.7B |
| May 15, 2026 | — | KRW 393 | — | KRW 72.1B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 16, 2026